Hereditary Renal Glycosuria, Diabetes, and Responses to SGLT2 Inhibitor

被引：0
|
作者：
Ren, Qian
Gong, Siqian
Han, Xueyao
Ji, Linong
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-774-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
774-P
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Bexagliflozin (Brenzavvy) - A Fifth SGLT2 Inhibitor for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1683): : 130 - 132
  • [22] Is an SGLT2 inhibitor right for your patient with type 2 diabetes?
    Lisenby, Katelin M.
    Meyer, Allison
    Slater, Nicole A.
    JOURNAL OF FAMILY PRACTICE, 2016, 65 (09): : 587 - 593
  • [23] Insulin Independence With SGLT2 Inhibitor Use in Type 2 Diabetes
    Jack, Gwendolyne Anyanate
    Kashyap, Sangeeta R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (10): : E1153 - E1154
  • [24] Ketoacidosis in Type 2 Diabetes with and without SGLT2 Inhibitor Therapy
    Koerbel, Theresa
    Zitterl, A.
    Jagoutz, T.
    Peric, S.
    Stulnig, T. M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S765 - S765
  • [25] Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus
    Kaushal, Shaveta
    Singh, Harmanjit
    Thangaraju, Pugazhenthan
    Singh, Jasbir
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2014, 6 (03) : 107 - 113
  • [26] Canagliflozin, a Novel SGLT2 Inhibitor for Treatment of Type 2 Diabetes
    Nigro, Stefanie C.
    Riche, Daniel M.
    Pheng, Michelle
    Baker, William L.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (10) : 1301 - 1311
  • [27] Discovery of a Novel Dual SGLT1 and SGLT2 Inhibitor for Diabetes Therapy
    Xu, Yao-Chang
    Li, Chenghai
    Wang, Juanjuan
    Liao, Jianchun
    Gao, Peng
    Bao, Rudi
    Yu, Hongping
    DIABETES, 2015, 64 : A660 - A660
  • [28] Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glycosuria to the treatment of type 2 diabetes mellitus
    Perez Lopez, G.
    Gonzalez Albarran, O.
    Cano Megias, M.
    NEFROLOGIA, 2010, 30 (06): : 618 - 625
  • [29] SGLT2 inhibitors and renal complications in type 1 diabetes
    Petrie, John R.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (10): : 803 - 805
  • [30] SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
    Chino, Yukihiro
    Samukawa, Yoshishige
    Sakai, Soichi
    Nakai, Yasuhiro
    Yamaguchi, Jun-ichi
    Nakanishi, Takeo
    Tamai, Ikumi
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (07) : 391 - 404
12345